It’s Their Own Fault We No Longer Default to Respect
Did This Issue Catapult Japanese Conservatives to a Landslide Win in Their Elections?
US Women's Hockey Team Clubbed the Canadians Like Baby Seals Yesterday. Oh, and...
Of Course, This GOP Senator Stabbed Us in the Back on Election Integrity
Why This Girl Wrestler Had Shock and Horror All Over Her Face in...
Bill Maher Reveals Why He Got the COVID Vaccine...and He's Rather Annoyed About...
Iran Is Preparing for a US Airstrike – Here's What Trump Is Saying
The Trump Economy Continues to Roar With 'Blockbuster' January Jobs Report
TX State Rep. Harrison Calls for Gene Wu to Be Stripped of Committee...
Check Out This Ridiculous Axios Headline About Plummeting Crime Rates
Police Released Person of Interest Detained in Guthrie Disappearance. Here's What We Know.
Report: The FAA Just Closed El Paso Airspace for Ten Days Over 'Security...
Public Opinion: A Tyrant Against Hard Decisions
Misconduct Rampant: America’s Leaders Increasingly Prioritize Agendas Over Fairness, Laws
2026 Olympics: Let’s Talk About Crotch Scandals
Tipsheet

Tulsi Gabbard: The Biden Administration Is Promoting Child Abuse

(AP Photo/John Minchillo)

Former Democratic Congresswoman Tulsi Gabbard took to her social media pages over the weekend to highlight a new Food and Drug Administration warning about puberty blockers. 

Advertisement

According to the FDA, these drugs can cause blindness and other permanent injuries when taken by children. 

The Food and Drug Administration (FDA) has added a warning about the risk of pseudotumor cerebri (idiopathic intracranial hypertension) to the labeling for gonadotropin-releasing hormone (GnRH) agonists that are approved for the treatment of central precocious puberty in pediatric patients. These products include Lupron Depot-Ped (leuprolide acetate), Fensolvi (leuprolide acetate), Synarel (nafarelin), Supprelin LA (histrelin) and Triptodur (triptorelin).

The new warning includes recommendations to monitor patients taking GnRH agonists for signs and symptoms of pseudotumor cerebri, including headache, papilledema, blurred or loss of vision, diplopia, pain behind the eye or pain with eye movement, tinnitus, dizziness and nausea.

The FDA assessed the potential risk of pseudotumor cerebri with use of GnRH agonists in pediatric patients by reviewing post-marketing safety data submitted by the GnRH agonist manufacturers, searching the FDA Adverse Event Reporting System and conducting a literature search.

Advertisement

Related:

JOE BIDEN

For months the Biden administration has been in a full court press to "affirm" gender "care" for children. That so-called "care" includes using taxpayer dollars to pay for puberty blockers and medical castration for young kids through Medicaid. 

"Providing resources on the importance of gender affirming care for children and adolescents. The Office of the Assistant Secretary for Health has developed a resource to inform parents and guardians, educators, and other persons supporting children and adolescents with information on what is gender-affirming care and why it is important to transgender, nonbinary, and other gender expansive young people’s well-being," the White House released in a March "fact sheet." 

Biden's U.S. Assistant Secretary of Health Dr. Levine has repeatedly stressed the "necessity" for children to be encouraged to use these kinds of drugs. 

Advertisement

During Levine's confirmation hearing, Republican Senator Dr. Rand Paul asked about Levine's support for these dangerous drugs. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos